Johnson & Johnson Innovation – JJDC
Corporate VCNew Brunswick · Seed–Growth · 41 people tracked
Investment thesis
Johnson & Johnson Innovation seeks to unlock the potential of life science innovation regardless of where it originates. It pairs Johnson & Johnson's internal expertise with promising external innovation from around the world to solve major health challenges and drive scientific breakthroughs. The organization operates across the innovation lifecycle: forming early innovation partnerships to accelerate early-stage ideas, incubating startups through its global JLABS network and community of innovators, providing venture capital through JJDC, and building late-stage partnerships offering access, resources, expertise, and commitment.
Source: firm website, verified Aug 3, 2026.
Team · 41 people
from the firm's website & public directories
What they invest in
from 14 of 15 portfolio companiesHealthtech ×12Biotech ×8Medical Devices ×5AI & Machine Learning ×4Deep Tech ×2Crypto & Web3 ×1Data & Infrastructure ×1Digital Health ×1
HQs:United States×9Ireland×1
Investments · 15 tracked
founders shown can be your intro pathBy year:2026 · 12025 · 12024 · 12019 · 12015 · 15 dated
Bright Peak Therapeutics is a biotechnology company developing multi-functional PD-1 inhibitors for cancer immunotherapy, based on its EDC protein-engineering platform.
BiotechHealthtechSan Diego, US
Vijaya Pattabiraman(Co-founder & Chief Technology Officer)Jeffrey Bode(Scientific Co-founder)Fredrik Wiklund(Chief Executive Officer)Christine Siu(Director)Michael Rosenzweig(Director)Bertolt Kreft(Executive Officer)
Co-investorsRA CapitalVersant VenturesVenrockFidelity InvestmentsInvusQatar Investment Authority
CuraSen Therapeutics is a privately funded biopharmaceutical company developing treatments that selectively activate adrenergic receptors in the brain to restore noradrenergic signaling.
BiotechHealthtech
Anthony Fordin
Co-investorsAlta PartnersLongitude Capitalabrdn plcIntermediate Capital GroupNew Leaf Venture PartnersPappas Capital+2 more
Loci Orthopaedics develops extremity orthopaedic technologies, including its InDx device for the thumb base joint, using evidence-based design to address unmet clinical needs.
HealthtechMedical DevicesGalway, IE
Brendan Boland(Co-founder & Executive Chairperson)Gerry(Co-founder)Barry(CEO)Paul(Finance Leader)John(VP Technical Operations)
Co-investorsSeroba Life Sciences
Mestag Therapeutics is an immunology company developing first-in-class agonist antibody therapies for cancer and inflammatory diseases based on fibroblast biology, and operates a RAFT platform for discovering new drug targets.
AI & Machine LearningBiotechHealthtech
Susan Hill(Founder & Chief Executive Officer)Michael B. Brenner(Founder)Chris Buckley(Founder)Mark Coles(Founder)Soumya Raychaudhuri(Founder)David A. Tuveson(Founder)
Co-investorsGV (Google Ventures)ForbionNorthpond VenturesSV Health Investors
ONL Therapeutics is a clinical-stage biopharmaceutical company developing therapies to preserve sight by preventing Fas-mediated death of retinal cells, a cause of vision loss and blindness.
BiotechHealthtechMedical DevicesAnn Arbor, US
David Zacks(Co-Founder & Chief Scientific Officer)David Esposito(Executive Officer, Director)Constance Chang(Executive Officer)John K Freshley(Executive Officer, Director)Jeffrey A Jamison(Executive Officer)David N Zacks(Executive Officer, Director)
Co-investorsExSight VenturesInvest MichiganNovartis Venture FundVisionary VenturesBios PartnersInFocus Capital Partners, LLC+3 more
Orasis is a pharmaceutical company developing drugs for the eye, operating in the ophthalmology and eyecare space.
BiotechHealthtechMedical Devices
Co-investorsArboretum VenturesMaverick Ventures IsraelVisionary VenturesCatalio Capital ManagementLifeSci Venture PartnersSequoia Capital+1 more
SpectraWAVE develops optical and computational imaging technologies to diagnose and guide treatment decisions for patients with coronary artery disease and cardiovascular disease.
AI & Machine LearningDeep TechHealthtechMedical DevicesBedford, US
Eman Namati(President & CEO)Guillermo Tearney(Founder; Professor of Pathology, Massachusetts General Hospital)Gregg Stone(Founder; Professor of Medicine, Mount Sinai Heart Health System)James Muller(Founder; Cardiologist, Brigham and Women's Hospital)Jeffrey O'Donnell(Founder; Managing General Partner, Runway Healthcare)Vivek Walimbe(Chief Operating Officer)
Co-investorsLumira VenturesS3 VenturesSV Health InvestorsDeerfield Management Company
Georgiamune is a biopharmaceutical company developing targeted immunomodulator drugs that activate or down-modulate immune signaling pathways to treat cancer and autoimmune diseases.
BiotechDeep TechHealthtechGaithersburg, US
Samir N. Khleif(Founder & CEO)Ramy Ibrahim(Chief Medical and Strategy Officer)Mikayel Mkrichyan(Senior Vice President of Science and Discovery)Sarah Sharman(Vice President of IP Legal Affairs)Sean Parker(Director)Paul Brown(Director)
Board seatNancy Ondovik· per SEC Form D · $131.9M raise · filed Aug 2026
Co-investorsCatalio Capital Management, LPHAWKTAILLauder PartnersPrevail Venture CapitalGeneral Catalyst
Accent Therapeutics is a biotechnology company focused on discovering and developing small molecule drugs to improve health outcomes for cancer patients.
BiotechHealthtechLongevity
Co-investorsAtlas VentureDroia VenturesEcoR1 CapitalGV (Google Ventures)The Column GroupJJDC+1 more
ARO Network is an edge network infrastructure platform designed for AI agents to operate on local devices and residential networks using users' real-world resources.
AI & Machine LearningCrypto & Web3Data & Infrastructure
Co-investorsCVP NoLimitEv3 Ventures LlcNo Limit Holdings (NLH)17SigmaNorte VenturesOnevc Venture Partners Llc
Fusion Pharma develops targeted alpha therapeutics that link alpha-emitting medical isotopes to molecules targeting biomarkers on cancer cell surfaces to selectively kill tumor cells.
BiotechHealthtech
Co-investorsFACIT (Fight Against Cancer Innovation Trust)HealthCapLumira VenturesSeroba Life SciencesVenture OntarioYsios Capital+2 more
Solenic Medical is a medical company; this page is an investor contact form and does not describe the company's products or technology in detail.
Medical DevicesCollege Station, US
James Y Lancaster(Executive Officer, Director)
BoardJohn Hodock(Director)Robert Calvin Goforth(Director)
Co-investorsShangBay Capital LLCSugati Ventures
HealthtechStamford, US
Patrick Lopath(Chief Operating Officer)Thomas Alan Dunlap(Chief Executive Officer)Madhu Ayyagari(Chief Executive Officer)
BoardRichel Liu(Director)Deng Mao(Director)Hirak Parikh(Director)
Astoria, US
Demetrius Michael Karagas(Executive Officer, Director)Steven Craig Gutentag(Executive Officer, Director)Steven Gutentag(Founder)in
BoardRebecca Kaden(Director)in
Co-investorsComcast VenturesConnetic VenturesCVS Health VenturesEvolution VC PartnersForeground CapitalGreycroft+11 more
Welldoc develops an AI-driven digital health platform focused on cardiometabolic disease management, providing personalized treatment solutions for patients with diabetes and related conditions.
AI & Machine LearningDigital HealthHealthtechBaltimore, US
Ryan Sysko(Executive Officer, Director)Suzanne Clough(Executive Officer)Kevin McRaith(President and CEO)Anand Iyer(Chief AI Officer)Chris Bergstrom(Executive Officer)Anand K. Iyer(Executive Officer)
Co-investorsMerck Global Health Innovation FundSamsung VenturesAsset Management CompanyDigiTx Partners LLCExcel Venture ManagementTCP Venture Capital+1 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.
Portfolio news
latest coverage across their companiesTECLens · hartfordbusiness.com · Aug 24, 2026
Solenic Medical · beckersspine.com · Jun 23, 2026
ARO Network Computing Resource Coordination · latamrepublic.com · Apr 29, 2026
Bright Peak Therapeutics · s-ge.com · Nov 4, 2025
Curasen · nasdaqprivatemarket.com · Mar 2, 2025
Frequently asked questions
- What stage does Johnson & Johnson Innovation – JJDC invest at?
- Johnson & Johnson Innovation – JJDC invests at the Seed, Series A, Series B, Series C, Growth stages.
- What sectors does Johnson & Johnson Innovation – JJDC focus on?
- Johnson & Johnson Innovation – JJDC focuses on Biotech, Digital Health, Healthtech, Medical Devices.
- Where is Johnson & Johnson Innovation – JJDC located?
- Johnson & Johnson Innovation – JJDC is headquartered in New Brunswick, US.
Images
Co-investors · 39
Venrock is a venture capital firm investing across technology and healthcare, backing companies in fintech, developer infrastructure, life sciences, therapeutics, semiconductors, and consumer products.
Atlas Venture is a life sciences venture capital firm with three decades of experience investing in and building biotech and medical innovation companies, including startups launched from its own incubator.
RA Capital is a multi-stage investment firm focused on healthcare, life sciences, and planetary health, investing across public and private markets and creating new companies through its Raven incubation platform.
New Leaf Venture Partners is a venture capital firm investing in innovative healthcare companies.
Lightspeed is a global venture capital firm that has spent over two decades backing innovative companies as an early and first investor.
Canaan Partners is a venture capital firm with over 30 years of history, backing companies across technology and healthcare sectors through close, hands-on partnerships with founders.
Plug and Play is an innovation platform that connects corporations, governments, startups, investors, and universities to drive innovation.
Acrew Capital is a venture capital firm that emphasizes a team-based approach to investing, offering portfolio companies access to its full team.
Polaris Partners is a venture capital firm that partners with biotech and healthcare entrepreneurs to build transformational companies.
Wildcat Venture Partners is a venture capital firm that backs technology entrepreneurs aiming to create new market categories.
ARCH Venture Partners is a venture capital firm that invests in and helps build transformational companies, with a strong focus on the life sciences and biotechnology sector.
Highbury is a venture capital firm that invests in, advises, and builds early-stage companies across frontier sectors. The firm takes concentrated positions and maintains long-term partnerships with founders solving compounding problems.
▶27 more co-investors
Flare Capital PartnersCherubic VenturesOUP (Osage University Partners)Illuminate VenturesFoothill VenturesSR One Capital ManagementBioGeneration VenturesDomain AssociatesThird Rock VenturesFlagship PioneeringPivotal Life SciencesKurma PartnersSofinnova VenturesAisling CapitalHatteras Venture PartnersAdvent Life SciencesLightstone VenturesVantagePoint Capital Partners1955 CapitalVida VenturesMedical Excellence CapitalVensana CapitalHealthy VenturesVertex Ventures HCSante VenturesAberdare VenturesAvedro, Inc.
Firms observed investing alongside Johnson & Johnson Innovation – JJDC, from public investor directories. Shared companies are the overlap with Johnson & Johnson Innovation – JJDC's recorded portfolio.
Similar investors
Amadeus Capital Partners is a technology investment firm that backs founders building complex, science-led and deep tech businesses, supporting them over the long term as they scale internationally.
.jpeg){kind=logo}
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
Breyer Capital is a venture capital firm that backs high-impact entrepreneurs, making strategic investments guided by founder passion and its network of experienced investors.
Capricorn Partners is a Belgium-based, partner-owned independent management company for alternative investment funds, investing in innovative companies across digital, health and clean technologies with an ESG focus.
DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.